Tag Archives: BLCM

15 Biggest Mid-Day Losers For Thursday

Related Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol-Myers Squibb Partnership; Medgenics Shares Slide 15 Biggest Mid-Day Losers For Monday Cerulean Pharma's (CERU) CEO Chris Guiffre on Cerulean and Dar茅 Proposed Transaction (Transcript) (Seeking Alpha) Related Mid-Afternoon....More>>>

Juno Therapeutics Q4 Earnings Report: What to Expect?

The Q4 2016 earnings report of mid cap cancer stock Juno Therapeutics Inc(NASDAQ: JUNO) is scheduled for after the market closes onWednesday (March 1st).Juno Therapeutics was inour SmallCap Network Elite Opportunity (SCN EO) portfolio in the past because thecompanywas well capitalized and had promising novel cellular immunotherapies based platforms (Immunotherapy involves engineering a....More>>>